BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15266333)

  • 1. Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours.
    Sakamoto A; Yokoyama Y; Umemoto M; Futagami M; Sakamoto T; Bing X; Mizunuma H
    Br J Cancer; 2004 Aug; 91(4):633-8. PubMed ID: 15266333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.
    Klimp AH; Hollema H; Kempinga C; van der Zee AG; de Vries EG; Daemen T
    Cancer Res; 2001 Oct; 61(19):7305-9. PubMed ID: 11585770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S; Inoue H; Flowers LC; Sidell N
    Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; IƱiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
    Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
    Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors.
    Pang L; Nie M; Corbett L; Knox AJ
    J Immunol; 2003 Jan; 170(2):1043-51. PubMed ID: 12517972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis.
    Badawi AF; Badr MZ
    Int J Cancer; 2003 Jan; 103(1):84-90. PubMed ID: 12455057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages.
    Janabi N
    J Immunol; 2002 May; 168(9):4747-55. PubMed ID: 11971025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.
    Subbaramaiah K; Lin DT; Hart JC; Dannenberg AJ
    J Biol Chem; 2001 Apr; 276(15):12440-8. PubMed ID: 11278336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
    Hashimoto K; Ethridge RT; Evers BM
    Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feedback control of cyclooxygenase-2 expression through PPARgamma.
    Inoue H; Tanabe T; Umesono K
    J Biol Chem; 2000 Sep; 275(36):28028-32. PubMed ID: 10827178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of PPAR activators on cytokine-stimulated cyclooxygenase-2 expression in human colorectal carcinoma cells.
    Ikawa H; Kameda H; Kamitani H; Baek SJ; Nixon JB; Hsi LC; Eling TE
    Exp Cell Res; 2001 Jul; 267(1):73-80. PubMed ID: 11412039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation.
    Na HK; Surh YJ
    Biochem Pharmacol; 2003 Oct; 66(8):1381-91. PubMed ID: 14555212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
    Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma.
    Zhang GY; Ahmed N; Riley C; Oliva K; Barker G; Quinn MA; Rice GE
    Br J Cancer; 2005 Jan; 92(1):113-9. PubMed ID: 15583697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.
    Straus DS; Pascual G; Li M; Welch JS; Ricote M; Hsiang CH; Sengchanthalangsy LL; Ghosh G; Glass CK
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4844-9. PubMed ID: 10781090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1.
    Sales KJ; Katz AA; Howard B; Soeters RP; Millar RP; Jabbour HN
    Cancer Res; 2002 Jan; 62(2):424-32. PubMed ID: 11809691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone, a specific ligand of the peroxisome proliferator-activated receptor gamma reduces gastric mucosal injury induced by ischaemia/ reperfusion in rat.
    Konturek PC; Brzozowski T; Kania J; Kukharsky V; Bazela K; Kwiecien S; Harsch I; Konturek SJ; Hahn EG
    Scand J Gastroenterol; 2003 May; 38(5):468-76. PubMed ID: 12795455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 expression in borderline ovarian tumors.
    Ferrandina G; Zannoni GF; Ranelletti FO; Legge F; Gessi M; Salutari V; Gallotta V; Lauriola L; Scambia G
    Gynecol Oncol; 2004 Oct; 95(1):46-51. PubMed ID: 15385109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.